To sum up, the concordant findings at the clinical and molecular levels, with less aggressive behavior and FGFR3 mutations in pure compared to mixed LNUC, indicate the possibility of different tumor entities despite the histomorphologically concordant LNUC component. This evidence concerns the gene FGFR3 and neoplasm.